National Health Investors (NYSE:NHI – Get Free Report) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Tuesday, Zacks reports.
Other equities research analysts have also issued reports about the company. BMO Capital Markets restated an “outperform” rating on shares of National Health Investors in a research note on Wednesday, September 23rd. Wells Fargo & Company lowered their target price on National Health Investors from $79.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Tuesday, September 1st. Weiss Ratings downgraded National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, September 25th. Truist Financial lowered their price objective on National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, September 2nd. Finally, Huntington assumed coverage on National Health Investors in a research note on Thursday, September 10th. They set an “outperform” rating and a $79.00 price objective for the company. Five investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $82.25.
Check Out Our Latest Analysis on NHI
National Health Investors Price Performance
National Health Investors (NYSE:NHI – Get Free Report) last posted its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The company had revenue of $121.32 million for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities research analysts anticipate that National Health Investors will post 4.76 earnings per share for the current year.
Institutional Trading of National Health Investors
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Allworth Financial LP purchased a new position in National Health Investors in the 2nd quarter worth approximately $42,000. EverSource Wealth Advisors LLC grew its holdings in National Health Investors by 34.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock valued at $51,000 after buying an additional 160 shares in the last quarter. Field & Main Bank purchased a new stake in National Health Investors during the 2nd quarter valued at approximately $76,000. Rockefeller Capital Management L.P. raised its position in shares of National Health Investors by 80.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,022 shares of the real estate investment trust’s stock valued at $78,000 after buying an additional 456 shares during the last quarter. Finally, Integrated Wealth Concepts LLC bought a new stake in shares of National Health Investors during the second quarter valued at approximately $84,000. Institutional investors own 62.51% of the company’s stock.
National Health Investors Company Profile
National Health Investors, Inc (NYSE:NHI) is a self-managed real estate investment trust that owns and finances healthcare-related real estate. The company primarily invests in properties used by seniors and patients, including senior housing communities, skilled nursing facilities, medical office buildings and other healthcare facilities.
NHI generally leases its properties to healthcare operators under long-term agreements and may provide mortgage or other financing to support the development and operation of healthcare real estate.
Recommended Stories
- Five stocks we like better than National Health Investors
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
